Decrease in the concentrations of transforming growth factor-beta1 in the sera of patients with kawasaki disease

Scandinavian Journal of Rheumatology

Volumn 26, Issue 4, 1997, Pages 314-322

  Matsubara, T ^a,b   Umezawa, Y ^a   Tsuru, S ^b   Motohashi, T ^a   Yabuta, K ^a   Furukawa, S ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Kawasaki disease; Soluble tumor necrosis factor receptor; Transforming growth factor beta1

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; INFLAMMATION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; SERUM; VASCULITIS;

EID: 0030880521     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749709105322     Document Type: Article

References (23)

1. McCartney-Francis NL, Wahl SM. Transforming growth factor β : a matter of life and death. J Leukoc Biol 1994; 55:401-9.
2. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;10:1286-92.
3. Hausmann EH, Hao S-Y, Pace JL, Parmely MJ. Transforming growth factor β1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages. Infect Immun 1994;62:3625-32.
4. Furukawa S, Matsubara T, Jujo K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988;48:247-51.
5. Furukawa S, Imai K, Matsubara T, Yone K, Yachi A, Okumura K, et al. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum 1992;35:672-7.
6. Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr 1994;124:721-5.
7. Matsubara T, Furukawa S, Suzuki J, Yone K, Yabuta K. Tumor necrosis factor-α inhibitory activity in urine of Kawasaki disease. Clin Immunol Immunopathol 1992;63: 285-8.
8. Kawasaki T, Kosaki F, Osawa S, Shigematsu I, Yanagawa S. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54: 271-6.
9. Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Ministry of Health and Welfare, 1984.
10. Maury CPJ, Salo E, Pelkonen P. Circulating interleukin-1 beta in patients with Kawasaki disease. N Engl J Med 1988; 319:1670-1.
11. Ueno Y, Takano N, Kanekane H, Yokoi T, Yachie A, Miyawaki T, et al. The acute phase nature of interleukin-6 : studies in Kawasaki disease and other febrile illness. Clin Exp Immunol 1989;76:337-42.
12. Lin CY, Lin CC, Hwang B, Chiang BN. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993;152:309-12.
13. Nash MC, Shah V, Dillon MJ. Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol 1995;101:13-7.
14. Leung DYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989;ii:1298-301.
15. Johns LD, Flanders KC, Ranges GE, Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor β1. J Immunol 1991;147:1792-6.
16. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold R, Yin M, et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9.
17. Kulkarni AB, Huh C-G, Becker D, Geiser A, Light M, Flander KC, et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-4.
18. Christ M, NcCartney-Francis NL, Kulkarni AB, Ward JM, Mitzel DE, Mackall CL, et al. Immune dysregulation in TGF-β1-deficient mice. J Immunol 1994;153:1936-46.
19. Mokhtarian F, Shi Y, Shirazian D, Morgante L, Miller A, Grob D. Defective production of anti-inflammatory cytokine. TGF-β by T cell lines of patients with active multiple sclerosis. J Immunol 1994;152:6003-10.
20. Snowden N, Coupes B, Herrick A, Illingworth K, Jayson MIV, Brenchley PEC. Plasma TGFβ in systemic sclerosis: a cross-sectional study. Ann Rheum Dis 1994;53:763-7.
21. Coupes BM, Newstead CG, Short CD, Brenchley PEC. Transforming growth factor β1 in renal allograft recipients. Transplantation 1994;57:1727-31.
22. Kotecha S, Wangoo A, Silverman M, Shaw RJ. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr 1996;128:464-9.
23. Furukawa S, Matsubara T, Jujo K, Sasai K, Sugawara T et al: Reduction of peripheral blood macrophages monocytes in Kawasaki disease by intravenous gamma globulin. Eur J Pediatr 1990;150:43-7.